Eleonora (Nora) Lad, MD, PhD is a clinician scientist and retinal ophthalmologist with the primary goal of developing novel strategies for early diagnosis and treatment of age-related macular degeneration (AMD).
Dr. Lad specializes in the diagnosis and treatment of macular diseases, such as AMD, diabetic retinopathy, and retinal vascular diseases. She is involved in clinical trials and innovative therapies for the treatment of macular diseases. Dr. Lad is committed to providing the highest level of evidence-based patient care.
Dr. Lad’s career goal is to translate her doctoral training in neuroscience into developing innovative diagnostic and therapeutic approaches for AMD. Her research interests are the following:
1) investigating the role of neuroinflammation and abnormal protein aggregates in the pathogenesis of AMD and developing relevant treatments
2) visual function testing in dry AMD with the goal of establishing functional endpoints for future clinical studies in early AMD
3) elucidating the use of novel retinal imaging biomarkers for early diagnosis of aging diseases (AMD and Alzheimer’s disease). On these studies, she is collaborating with an interdisciplinary team of investigators from Ophthalmology, Geriatrics, Biomedical Engineering, Neurology and Alzheimer’s Disease Research Center.
Dr. Lad was awarded the Clinical Scientist Development Award from the National Eye Institute and is the recipient of the ARVO/Alcon Early Career Clinician-Scientist Research Award and Heed Foundation award. She is a member of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, International Society for Eye Research, Society of Heed Fellows, Society for Neuroscience and American Society for Neural Therapy and Repair.
Education and Training
- Albion College, B.S. 2000
- Rosalind Franklin University of Medicine and Science, Ph.D. 2005
- Rosalind Franklin University of Medicine and Science, M.D. 2007
- Stanford University School of Medicine, 3 Year Residency, Ophthalmology
- Duke University School of Medicine, Medical Retina Fellowship, Duke Eye Center